As FineHeart enters a pivotal phase in the clinical, industrial and international development of FlowMaker®, the company has welcomed Pierre Chauvineau to its Board of Directors. Chauvineau joins a highly experienced Board that supports FineHeart’s long-term vision to establish FlowMaker® as a differentiated therapeutic approach for advanced heart failure, a major unmet medical need. He brings more than 35 years of international leadership experience in the medtech industry, with extensive expertise in scaling innovative companies, driving global market expansion, and translating breakthrough technologies into clinical and commercial success.
FineHeart welcomes Pierre Chauvineau to board of directors
